Brief: Yumanity Therapeutics Reports Q3 Loss Per Share $0.97
15/11/2021 12:51
Nov 15 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q3 LOSS PER SHARE $0.97
Source text for Eikon: ID:nGNX9R51C0
Further company coverage: YMTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study